Persistent accumulation of interferon-γ-producing CD8+CD56+ T cells in blood from patients with coronary artery disease
Related Experiment Video
Updated: May 19, 2026

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
Ida Bergström1, Karin Backteman, Anna Lundberg
1Department of Medical and Health Sciences, Division of Cardiovascular Medicine, Faculty of Health Sciences, Linköping University, SE-58185 Linköping, Sweden.
Insights
Coronary artery disease patients show increased CD8(+)CD56(+) T cells, linked to immune aging and potentially worsening atherosclerosis. These cells produce more interferon-gamma, impacting disease progression.
Area of Science:
- Immunology
- Cardiovascular Disease Research
Background:
- Emerging evidence suggests CD8(+) T cell alterations in coronary artery disease (CAD).
- CD8(+)CD56(+) T cells represent a distinct T cell subset with potential roles in immune responses.
Purpose of the Study:
- To investigate differences in CD8(+)CD56(+) T cell distribution and phenotype in patients with varying clinical manifestations of CAD.
- To compare these cells between acute coronary syndrome (ACS), stable angina (SA), and control groups.
Main Methods:
- Flow cytometry was used to analyze CD8(+)CD56(+) T cells in blood samples from ACS (n=30), SA (n=34), and control (n=36) patients.
- Assessment included surface marker expression, apoptosis, and intracellular cytokine production (IFN-γ, TNF).
- Samples were collected pre- and post-intervention (3 and 12 months).
Main Results:
- Proportions of CD8(+)CD56(+) T cells were significantly higher in ACS and SA patients compared to controls, persisting up to 12 months.
- These cells exhibited lower CD28 expression and reduced apoptosis compared to CD8(+)CD56(-) T cells.
- While both subsets produced IFN-γ and TNF, IFN-γ was more concentrated in CD8(+)CD56(+) T cells.
Conclusions:
- Persistent accumulation of CD8(+)CD56(+) T cells in CAD patients resembles immunological aging.
- These cells contribute to an expanded IFN-γ(+) pool, potentially promoting atherosclerosis.
- Understanding these T cell alterations may offer insights into CAD pathogenesis and progression.
Objective:
There is emerging evidence for CD8(+) T cell alterations in blood from patients with coronary artery disease (CAD). We examined whether the distribution and phenotype of CD8(+)CD56(+) T cells differed according to the clinical manifestation of CAD.
Methods:
Patients with acute coronary syndrome (ACS, n = 30), stable angina (SA, n = 34) and controls (n = 36) were included. Blood was collected before and up to 12 months after referral for coronary investigation. CD8(+)CD56(+) T cells were assessed by flow cytometry for expression of surface markers, apoptosis, and intracellular expression of cytokines.
Results:
The proportions of CD8(+)CD56(+) T cells were significantly higher in both ACS and SA patients compared with controls, and remained so after 3 and 12 months. This was independent of age, sex, systemic inflammation and cytomegalovirus seropositivity. CD8(+)CD56(+) T cells differed from CD8(+)CD56(-) T cells in terms of lower CD28 expression and fewer apoptotic cells. Both CD8(+) T cell subsets were positive for interferon (IFN)-γ and tumor necrosis factor, although IFN-γ was significantly more confined to the CD8(+)CD56(+) T cells.
Conclusion:
The persistent accumulation of CD8(+)CD56(+) T cells in ACS and SA patients share several features with immunological aging. It also contributes to a larger IFN-γ(+) pool in blood, and may thereby hypothetically drive the atherosclerotic process in a less favorable direction.
Related Concept Videos
Myocarditis I: Introduction
Inflammation
Coronary Artery Disease II: Pathophysiology
Chronic Inflammation: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
